[1] Rang,Dale,Ritter,Moore,Pharmacology,  (2003), 5ª Edition, Churchill Livingstone, 274-277

[2] http://toxnet.nlm.nih.gov

[3] http://www.infomed.pt/infomed

​

[4] Budavari S, O'neil M, et al.The Index Merck, 12th edition (1996),Merck research laboratory, 218

​

[5] http://www.nlm.nih.gov/medlineplus/druginfo/meds/a687009.HTML

​

[6] Sujeeth R. Punnam, Sandeep K. Goyal, Veera Pavan K. Koturu, Ajay R. Pachika, George S. Abela and Ranjan K. Thakur, "Amiodarona - A ´Broad Spectrum´Antiarrhytmic Drug", Cardiovascular & Haematological Disorders - Drug Targets, 2010, 10, 73-81

​

[7] Serafim Guimarães, Daniel Moura e Patrício Soares da Silva, "Terapêutica Medicamentosa E Suas Bases Farmacológicas", Manual de Farmacologia e Farmacoterapia, 5ª Edição, Porto Editora, 2006



[8] Vincent Yi-Fong Su, Yu-Wen Hu, Kun-Ta Chou, Shuo-Ming Ou, Yu-Chin Lee, Elizabeth Ya-Hsuan Lin, Tzeng-Ji Chen, Cheng-Hwai Tzeng, and Chia-Jen Liu. “Amiodarone and the risk of cancer: A nationwide population-based study.” CANCER; April 8, 2013.



[9] Renata Pavan, Alexandre M.X. de Jesus, Léa M.Z. Maciel - A Amiodarona e a Tireóide - Arq Bras Endocrinol Metab, vol 48, nº 1, Fevereiro 2004.

​

[10] Maria Vítor Campos - EFEITOS DA AMIODARONA NA TIRÓIDE: Aspectos atuais - Acta Méd Port 2004; 17: 241-246



[11] N. Wolkove, M. Baltzan, Amiodarone pulmonary toxicity. Can respir J 2009;16(2):43-48.





​

​

​

​

​

​